Inappropriate sinus tachycardia: focus on ivabradine

被引:21
作者
Abed, H. S. [1 ,2 ]
Fulcher, J. R. [1 ,2 ]
Kilborn, M. J. [1 ,2 ]
Keech, A. C. [1 ,2 ]
机构
[1] Univ Sydney, Dept Cardiol, Royal Prince Alfred Hosp, K25 Med Fdn Bldg, Sydney, NSW 2006, Australia
[2] Univ Sydney, NHMRC Clin Trials Ctr, K25 Med Fdn Bldg, Sydney, NSW 2006, Australia
关键词
inappropriate sinus tachycardia; ivabradine; JUNCTIONAL RECIPROCATING TACHYCARDIA; RADIOFREQUENCY CATHETER ABLATION; F INHIBITOR IVABRADINE; DOUBLE-BLIND; HEART-RATE; EFFICACY; ARRHYTHMIAS; RATIONALE; MECHANISM; CROSSOVER;
D O I
10.1111/imj.13093
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Inappropriate sinus tachycardia (IST) is an incompletely understood condition, characterised by an elevation in heart rate (HR) accompanied by wide ranging symptoms in the absence of an underlying physiological stimulus. The condition often takes a chronic course with significant adverse effects on quality of life. Currently, there is no effective treatment for IST. Beta-blockers, generally considered the cornerstone of treatment, are often ineffective and poorly tolerated. Ivabradine is a novel sinus node I-f funny current' inhibitor, which reduces the HR. It has been approved for the treatment of beta-blocker refractory chronic systolic heart failure and chronic stable angina but more recently has shown promise in the treatment of IST. This review provides an overview of IST prevalence and mechanisms followed by an examination of the evidence for the role and efficacy of ivabradine in the treatment of IST.
引用
收藏
页码:875 / 883
页数:9
相关论文
共 30 条
[1]
Peptidic regulation of heart rate and interactions with the autonomic nervous system [J].
Beaulieu, P ;
Lambert, C .
CARDIOVASCULAR RESEARCH, 1998, 37 (03) :578-585
[2]
Long-Term Outcomes of Ivabradine in Inappropriate Sinus Tachycardia Patients: Appropriate Efficacy or Inappropriate Patients [J].
Benezet-Mazuecos, Juan ;
Rubio, Jose M. ;
Farre, Jeronimo ;
Quinones, Miguel A. ;
Sanchez-Borque, Pepa ;
Macia, Ester .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2013, 36 (07) :830-836
[3]
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias -: Executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) [J].
Blomström-Lundqvist, C ;
Scheinman, MM ;
Aliot, EM ;
Alpert, JS ;
Calkins, H ;
Camm, AJ ;
Campbell, WB ;
Haines, DE ;
Kuck, KH ;
Lerman, BB ;
Miller, DD ;
Shaeffer, CW ;
Stevenson, WG ;
Tomaselli, GF ;
Antman, EM ;
Smith, SC ;
Alpert, JS ;
Faxon, DP ;
Fuster, V ;
Gibbons, RJ ;
Gregoratos, G ;
Hiratzka, LF ;
Hunt, SA ;
Jacobs, AK ;
Russell, RO ;
Priori, SG ;
Blanc, JJ ;
Budaj, A ;
Burgos, EF ;
Cowie, M ;
Deckers, JW ;
Garcia, MAA ;
Klein, WW ;
Lekakis, J ;
Lindahl, B ;
Mazzotta, G ;
Morais, JCA ;
Oto, A ;
Smiseth, O ;
Trappe, HJ .
CIRCULATION, 2003, 108 (15) :1871-1909
[4]
Efficacy of ivabradine administration in patients affected by inappropriate sinus tachycardia [J].
Calo, Leonardo ;
Rebecchi, Marco ;
Sette, Antonella ;
Martino, Annamaria ;
De Ruvo, Ermenegildo ;
Sciarra, Luigi ;
De Luca, Lucia ;
Zuccaro, Lorenzo Maria ;
Giunta, Giuseppe ;
Ciccaglioni, Antonio ;
Lioy, Ernesto ;
Fedele, Francesco .
HEART RHYTHM, 2010, 7 (09) :1318-1323
[5]
Clinical Efficacy of Ivabradine in Patients With Inappropriate Sinus Tachycardia A Prospective, Randomized, Placebo-Controlled, Double-Blind, Crossover Evaluation [J].
Cappato, Riccardo ;
Castelvecchio, Serenella ;
Ricci, Cristian ;
Bianco, Elisabetta ;
Vitali-Serdoz, Laura ;
Gnecchi-Ruscone, Tomaso ;
Pittalis, Mario ;
De Ambroggi, Luigi ;
Baruscotti, Mirko ;
Gaeta, Maddalena ;
Furlanello, Francesco ;
Di Francesco, Dario ;
Lupo, Pier Paolo .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (15) :1323-1329
[6]
Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac β adrenergic receptors [J].
Chiale, Pablo A. ;
Garro, Hugo A. ;
Schmidberg, Jorge ;
Sanchez, Ruben A. ;
Acunzo, Rafael S. ;
Lago, Manuel ;
Levy, Gabriela ;
Levin, Mariano .
HEART RHYTHM, 2006, 3 (10) :1182-1186
[7]
Department of Health and Ageing: Therapeutic Goods Administration, 2010, AUSTR PUBL ASS REP I
[8]
Clinical course of persistent junctional reciprocating tachycardia [J].
Dorostkar, PC ;
Silka, MJ ;
Morady, F ;
Dick, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (02) :366-375
[9]
The BEAUTIFUL study:: Randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction baseline characteristics of the study population [J].
Fox, Kim ;
Recena, J. Balaguer ;
Garcia-Aranda, V. Lopez ;
Valderrama, J. Caparros ;
Alonso, L. F. Iglesias ;
Calvar, A. San Roman ;
Aviles, F. Fernandez ;
Villa, F. Perez ;
Cortada, J. Bruguera ;
Alvarez, R. Fernandez ;
Peiro, F. Noriega ;
Iglesias, F. Calvo ;
Toral, B. Sevilla ;
Bescos, L. Lopez ;
De Burgos, F. Garcia ;
Casado, R. Sola ;
Galve, E. ;
Garcia, G. Casares ;
Dellborg, M. ;
Herlitz, J. ;
Ullman, B. ;
Blomgren, J. ;
Bandh, S. ;
Oehlin, H. ;
Dubach, P. ;
Gallino, A. ;
Hess, O. ;
Moccetti, T. ;
Eeckhout, E. ;
Vontobel, H. ;
Delabays, A. ;
Erol, K. ;
Kozan, O. ;
Mutlu, B. ;
Ergene, O. ;
Acarturk, E. ;
Yilmaz, H. ;
Ural, D. ;
Parkhomenko, O. ;
Polyvoda, S. ;
Dyadyk, A. ;
Vatutin, M. ;
Karpenko, O. ;
Kubyshkin, V. ;
Rudenko, L. ;
Putintsev, V. ;
Krayz, I. ;
Kovalsky, I. ;
Rudyk, Y. ;
Yurlov, V. .
CARDIOLOGY, 2008, 110 (04) :271-282
[10]
Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure [J].
Fox, Kim ;
Ford, Ian ;
Steg, Philippe Gabriel ;
Tardif, Jean-Claude ;
Tendera, Michal ;
Ferrari, Roberto .
AMERICAN HEART JOURNAL, 2013, 166 (04) :654-+